Apple seeks to expedite its appeal against a U.S. International Trade Commission patent ruling that mandated the company disable a feature on its Apple Watch designed to measure blood oxygen levels. However, both its legal competitor Masimo Corp and the ITC argue there is no urgent basis to prioritize this appeal. Details on the ongoing legal contention can be found here.